Clinimix E Injection
Product Images NDC 0338-1145

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Clinimix E (NDC 0338-1145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Instructional diagram showing four steps to prepare an intravenous CLINIMIX E injection bag. Steps include laying the container on a flat surface, rolling it to break the peel seal and mix components, turning it upside-down multiple times, and hanging the container to attach the spike connector after removing the protector from the administration outlet.*

FDA Label Image

Dextrose Hydrous Structural Formula (Image 02)

Illustrated step-by-step instructions for mixing and preparing a dual-chamber intravenous injection container. Steps include laying the room temperature container flat and grasping it, rolling it to break the peel seal between chambers causing an audible pop, mixing by turning the container upside down multiple times, and hanging the container before removing the protector and connecting the spike connector for administration.*

FDA Label Image

Clinimix E Representative Container Label 0338-1147 (Image 03)

Chemical structure of Dextrose Hydrous, USP (D-Glucose monohydrate). The structure shows the molecular arrangement including hydroxyl groups and a water molecule associated with the compound.*

FDA Label Image

Clinimix E Representative Carton Label 0338-1147 (Image 04)

CLINIMIX E Injection with Electrolytes 2.75% Amino Acids with Electrolytes in 5% Dextrose with Calcium Injection. The label includes details for a 500 mL injection port chamber (10% Dextrose Injection with Calcium) and a 500 mL outlet port chamber (5.5% Amino Acid Injection). It is a sterile single-dose container, manufactured by Baxter Healthcare Company in the USA, and lists contents per 100 mL including essential and nonessential amino acids, electrolytes, and instructions for activation, storage, and handling.*

FDA Label Image

Clinimix E Representative Container Label 0338-1145 (Image 05)

Label for CLINIMIX E 4.25/5 Injection with Electrolytes by Baxter Healthcare Company. It is a sulfite-free injection containing 4.25% amino acids with electrolytes in 5% dextrose with calcium. The label details 500 mL injection port chamber with 10% dextrose injection with calcium and 500 mL outlet port chamber with 8.5% amino acid injection. Additional information includes activation instructions, storage conditions, and a detailed contents list of amino acids and electrolytes per 100 mL of the admixed injection.*

FDA Label Image

Clinimix E Representative Carton Label 0338-1145-03 (Image 06)

CLINIMIX E Injection with Electrolytes, a sulfite-free intravenous amino acid injection containing 4.25% amino acids and 5% dextrose with calcium, in a 2000 mL mixed solution after preparation. The label details amino acid and electrolyte concentrations per 100 mL, storage instructions, and is labeled for prescription use by Baxter Healthcare Corporation.*

FDA Label Image

Clinimix E Representative Container Label 0338-1142 (Image 07)

CLINIMIX E 4.25/10 intravenous injection label showing 4.25% amino acids with electrolytes in 10% dextrose with calcium. The label indicates a 500 mL injection port chamber with 20% dextrose plus calcium and a 500 mL outlet port chamber with 8.5% amino acids. It includes instructions for activation and mixing, storage conditions, and lists contents per 100 mL for amino acids and electrolytes. Manufactured by Baxter Healthcare Company.*

FDA Label Image

Clinimix E Representative Carton Label 0338-1142 (Image 08)

CLINIMIX E 4.25/10 injection label showing a 4.25% amino acids with electrolytes in 10% dextrose with calcium formulation. The label specifies central line infusion only, two chambers containing 1000 mL each with 20% dextrose injection with calcium and 8.5% amino acid injection. It includes detailed ingredient amounts, electrolytes, and storage instructions. Labeler is Baxter Healthcare Corporation.*

FDA Label Image

Clinimix E Representative Container Label 0338-1107 (Image 09)

CLINIMIX E with Electrolytes Injection label showing a 500 mL dual-chamber intravenous product packaged for central line infusion. It contains 5% amino acids and 15% dextrose with calcium. The label lists detailed ingredient amounts including essential and nonessential amino acids, electrolytes, and electrolytes' mEq/L concentrations. The product is sulfite-free and from Baxter Healthcare Company, made in the USA, with storage and handling instructions.*

FDA Label Image

Clinimix E Representative Carton Label 0338-1107 (Image 10)

Label for CLINIMIX E 5/5 sterile intravenous injection by Baxter Healthcare Company, a prescription product containing 5% amino acids with electrolytes in 15% dextrose with calcium. The label details a 1000 mL dual-chamber infusion bag with 30% dextrose injection and 10% amino acid injection, emphasizing central line use and specific storage instructions. It lists active amino acids and electrolytes composition per 100 mL of admixed injection.*

FDA Label Image

Clinimix E Representative Container Label 0338-1143 (Image 11)

CLINIMIX E 5/20 Injection label by Baxter Healthcare Company indicating a sulfite-free formulation containing 5% amino acids with electrolytes and 20% dextrose with calcium for intravenous use. The package includes a 500 mL injection port chamber and outlet port chamber for central line infusion. The label lists detailed contents of amino acids and electrolytes per 100 mL of the admixed injection, along with handling and storage instructions.*

FDA Label Image

Clinimix E Representative Carton Label 0338-1143 (Image 12)

Label for CLINIMIX E 5/20 Injection by Baxter Healthcare Company. It is a 5% amino acids with electrolytes in 20% dextrose with calcium intravenous injection for central line infusion only. The 2000 mL product includes a 1000 mL injection port chamber of 40% dextrose with calcium and a 1000 mL outlet port chamber of 10% amino acid injection. The label lists detailed active ingredient amounts per 100 mL, including essential and nonessential amino acids and electrolytes. Storage instructions and usage precautions are also provided.*

FDA Label Image

Clinimix E Representative Container Label 0338-1109 (Image 13)

CLINIMIX E 8/14 injection label showing 1000 mL container size. The label indicates an 8% amino acids with electrolytes and 14% dextrose injection containing calcium, for central line infusion only. It is sulfite-free and includes directions for activation and storage limiting refrigeration to 9 days. The label lists essential and nonessential amino acids, electrolytes, and acetate per 100 mL. Manufactured by Baxter Healthcare Company.*

FDA Label Image

Clinimix E Representative Carton Label 0338-1109 (Image 14)

Label for CLINIMIX E 8/14 Injection, a sulfite-free 8% amino acids with electrolytes in 14% dextrose with calcium formulation. It is a central line infusion only, with a 720 mL injection port chamber and a 1280 mL outlet port chamber. The label lists the amino acids and electrolytes content per 100 mL, storage instructions, and manufacturing details by Baxter Healthcare Company in Belgium. The product volume is 2000 mL with NDC 0338-0206-01.*

FDA Label Image

Clinimix E Representative Container Label 0338-1144 (Image 15)

CLINIMIX E 8/10 Injection with Electrolytes is a 1000 mL intravenous solution from Baxter Healthcare Company. The label details an amino acid injection (8%) with electrolytes and 10% dextrose with calcium, for central line infusion only. It includes info on amino acids and electrolyte contents per 100 mL, storage instructions, and activation directions.*

FDA Label Image

Clinimix E Representative Carton Label 0338-1144 (Image 16)

CLINIMIX E 8% Amino Acids with Electrolytes in 10% Dextrose with Calcium Injection is a human prescription intravenous injection by Baxter Healthcare Company. The label states it is sulfite-free and for central line infusion only, featuring 720 mL injection port chamber and 1280 mL outlet port chamber. It includes detailed content of amino acids and electrolytes per 100 mL and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.